Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus®) in Chinese adults with type 2 diabetes mellitus: A Phase III, randomised, open-label, controlled trial

Compare the efficacy and safety of LY2963016 insulin glargine (LY IGlar) versus insulin glargine (Lantus®; IGlar) combined with oral antihyperglycaemic medications (OAMs) in insulin-naive Chinese patients with type 2 diabetes mellitus (T2DM). In this Phase III, open-label trial, adult patients with...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2021-03
Hauptverfasser:	Feng, Wenhuan, Chen, Wei, Jiang, Shan, Du, Liying, Zhu, Dalong
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!